Speaker Profile
M.D., Chief Medical Officer, International Society of Liquid Biopsy, UC Davis Health
Biography
Dr. David Gandara, renowned for his expertise in lung cancer and thoracic oncology, is a clinician-scientist at UC Davis Health. He is celebrated for his ability to convey complex medical concepts in an accessible manner, recognized by groups like the Addario Lung Cancer Foundation. Dr. Gandara's clinical practice focuses on second opinion consultations in thoracic cancers, emphasizing diagnostics like circulating tumor DNA and next-generation sequencing.A prolific researcher, Dr. Gandara has published over 450 peer-reviewed papers, mainly in developmental therapeutics and biomarker development in lung cancer. He leads significant clinical trials funded by the National Cancer Institute (NCI), exploring new anti-cancer agents. Additionally, he is the Chief Medical Officer of the International Society of Liquid Biopsy and holds leadership roles at UC Davis Cancer Center and the University of Hawaii Cancer Center. His work in patient care, research, and liquid biopsy places him at the forefront of oncological advancements.
Session Abstract – PMWC 2024 Silicon Valley
Track Chair: Laura J. van 't Veer, UCSF
- PMWC 2024 Award Ceremony
Pioneer Honoree: David Sidransky, Johns Hopkins
Pioneer Honoree: Helmy Eltoukhy
Pioneer Honoree: AmirAli Talasaz, Guardant Health - Utilities of Liquid Biopsy in Biomarker Testing
- Laura Vent Veer, UCSF - Status Quo of Clinical Liquid Biopsy (PANEL)
Chair: Helmy Eltoukhy, Guardant Health
- Sadakatsu Ikeda, Tokyo Medical University
- Heather Parsons, Dana-Farber Cancer Institute
- Sanjay Popat, The Royal Marsden - Liquid Biopsy for Health Monitoring and Disease Prevention (PANEL)
Chair: Anne-Renee Hartman, Adela Bio
- AmirAli Talasaz, Guardant Health
- Heather Parsons, Dana-Farber Cancer Institute
- Mary Pat Lancelotta, Adaptive Bio
- Sylvia Katina Plevritis, Stanford - Multi-Cancer Early Detection Through Multi-Biomarker Class Liquid Biopsy Testing (PANEL)
Chair: Tom Beer, Exact Sciences
- Wendy Rubinstein, National Cancer Institute
- Sheila D. Walcoff, Goldbug Strategies LLC - Keynote: Pioneering Liquid Nucleic Acids Tumor Fragments in Health and Diseases
- David Sidransky, Johns Hopkins - New Approaches in Liquid Biopsy (PANEL)
Chair: Victor Velculescu, Johns Hopkins
- David Sidransky, Johns Hopkins
- Dan Laudau, NY Genome Center
- Daniel De Carvalho, University of Toronto - Global Implications: A scalable Liquid Biopsy for HPV-related Cervical Cancer (PANEL)
Chair: Debra Fraser-Howze, D. Fraser Associates
- Belinda Nedjai, Wolfson Institute of Population Health
- Elisabeth Adams, Aquarius Population Health Limited - NCI Showcase
- Xiaohui Ni, Early Dx
- Daniel Kim, UCSC
